GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Ovid Technologies (Wolters Kluwer Health)  (1)
  • Cintra Lopes Carapeto, Fernando  (1)
  • Fernandes, Mariana  (1)
Material
Publisher
  • Ovid Technologies (Wolters Kluwer Health)  (1)
Person/Organisation
Language
Years
Subjects(RVK)
  • 1
    In: The American Journal of Dermatopathology, Ovid Technologies (Wolters Kluwer Health), Vol. 39, No. 2 ( 2017-02), p. 114-120
    Abstract: Samples of acral lentiginous melanomas (ALMs) were obtained from the Department of Pathology at Escola Paulista de Medicina—Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. Demographic, clinical, and follow-up data were obtained from the charts of Hospital São Paulo. From 2 tissue microarrays containing 60 nevi and quadruplicate samples of ≥1.0-mm of 49 ALM, sections were stained to evaluate SCF, KIT, BRAF, CYCLIND1, MYC, and PTEN immunohistochemical protein expression. Results: Nevi and ALM from 2006 to 2010 were reviewed and collected. All specimens were in the vertical growth phase, and histopathological parameters indicated that tumors were at an advanced stage at diagnosis. Average tumor thickness was 6.95 mm, 63% were ulcerated, average mitotic index was 5 mitotic cells per mm 2 , and 43% were at Clark's level V. Compared with nevi, the χ 2 test showed that ALM significantly correlated with SCF protein expression ( P = 0.001) and expression heterogeneity ( P 〈 0.000). Similar findings were observed for KIT ( P = 0.005, P = 0.003, respectively), MYC ( P 〈 0.000, P 〈 0.000), and PTEN ( P = 0.005, P 〈 0.000). Malignancy did not correlate with BRAF and CYCLIN D1 expression ( P = 0.053 and P = 0.259, respectively), but it did significantly correlate with their heterogeneous expression ( P 〈 0.000, P = 0.024, respectively). Combined protein expression had an odds ratio of greater malignancy when BRAF and MYC were positive and/or heterogeneously expressed (OR of 78 and 95, respectively). Discussion and Conclusion: We show that marker protein expression, when combined with heterogeneous expression as shown by immunohistochemistry, is a powerful indicator of malignancy in ALMs, especially, when protein pairs are combined.
    Type of Medium: Online Resource
    ISSN: 0193-1091
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2017
    detail.hit.zdb_id: 2041296-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...